2021 Q3 Form 10-Q Financial Statement

#000162828021018255 Filed on September 09, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q1 2020 Q3
Revenue $202.0M $177.9M $135.8M
YoY Change 48.66% 3.15% -16.01%
Cost Of Revenue $127.2M $119.7M $94.17M
YoY Change 35.1% -0.5% -14.4%
Gross Profit $74.73M $58.26M $41.67M
YoY Change 79.31% 11.75% -19.42%
Gross Profit Margin 37.0% 32.75% 30.68%
Selling, General & Admin $48.30M $44.10M $33.97M
YoY Change 42.21% 1.85% -14.25%
% of Gross Profit 64.64% 75.69% 81.5%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.485M $4.490M $4.970M
YoY Change -9.76% -20.11% -2.17%
% of Gross Profit 6.0% 7.71% 11.93%
Operating Expenses $48.30M $44.10M $33.97M
YoY Change 42.21% 1.61% -14.25%
Operating Profit $26.43M $14.11M $7.709M
YoY Change 242.81% 66.14% -36.34%
Interest Expense $43.00K $0.00 $300.0K
YoY Change -85.67%
% of Operating Profit 0.16% 0.0% 3.89%
Other Income/Expense, Net -$102.0K -$100.0K $311.0K
YoY Change -132.8% -116.67% -45.63%
Pretax Income $26.33M $14.00M $8.020M
YoY Change 228.24% 53.85% -36.76%
Income Tax $5.927M $5.100M $2.754M
% Of Pretax Income 22.51% 36.43% 34.34%
Net Earnings $20.40M $8.871M $5.266M
YoY Change 287.35% 41.42% -43.28%
Net Earnings / Revenue 10.1% 4.99% 3.88%
Basic Earnings Per Share $0.30 $0.18
Diluted Earnings Per Share $655.6K $0.29 $0.18
COMMON SHARES
Basic Shares Outstanding 30.50M shares 29.69M shares
Diluted Shares Outstanding 31.11M shares 29.70M shares

Balance Sheet

Concept 2021 Q3 2021 Q1 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $148.5M $141.1M $148.9M
YoY Change -0.25% 1.07% 19.62%
Cash & Equivalents $81.89M $76.18M $133.0M
Short-Term Investments $66.63M $64.93M $15.94M
Other Short-Term Assets $7.810M $805.0K $4.000M
YoY Change 95.25% 27.78% -16.67%
Inventory $86.85M $55.70M $68.07M
Prepaid Expenses
Receivables $13.14M $8.700M $13.30M
Other Receivables $0.00 $815.0K $0.00
Total Short-Term Assets $256.3M $211.7M $234.2M
YoY Change 9.45% 1.37% 9.42%
LONG-TERM ASSETS
Property, Plant & Equipment $51.17M $52.64M $56.81M
YoY Change -9.92% -20.46% -16.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $11.60M $1.273M $8.458M
YoY Change 37.16% -83.99% 285.51%
Total Long-Term Assets $278.8M $295.7M $310.3M
YoY Change -10.14% -12.45% -4.9%
TOTAL ASSETS
Total Short-Term Assets $256.3M $211.7M $234.2M
Total Long-Term Assets $278.8M $295.7M $310.3M
Total Assets $535.2M $507.5M $544.5M
YoY Change -1.71% -7.17% 0.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $59.05M $24.98M $48.71M
YoY Change 21.23% 21.5% 23.39%
Accrued Expenses $23.90M $30.68M $19.42M
YoY Change 23.08% 47.83% -15.99%
Deferred Revenue $1.800M
YoY Change 0.0%
Short-Term Debt $0.00 $0.00 $23.70M
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $166.5M $134.2M $172.9M
YoY Change -3.71% -7.62% 32.23%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.385M $1.351M $944.0K
YoY Change 46.72% 88.16% -20.14%
Total Long-Term Liabilities $1.385M $212.6M $944.0K
YoY Change 46.72% -11.94% -20.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $166.5M $134.2M $172.9M
Total Long-Term Liabilities $1.385M $212.6M $944.0K
Total Liabilities $363.9M $346.8M $395.9M
YoY Change -8.08% -10.32% 8.21%
SHAREHOLDERS EQUITY
Retained Earnings $5.782M $5.135M -$5.849M
YoY Change -198.85% -18.23% -125.11%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $171.2M $160.6M $148.6M
YoY Change
Total Liabilities & Shareholders Equity $535.2M $507.5M $544.5M
YoY Change -1.71% -7.17% 0.77%

Cashflow Statement

Concept 2021 Q3 2021 Q1 2020 Q3
OPERATING ACTIVITIES
Net Income $20.40M $8.871M $5.266M
YoY Change 287.35% 41.42% -43.28%
Depreciation, Depletion And Amortization $4.485M $4.490M $4.970M
YoY Change -9.76% -20.11% -2.17%
Cash From Operating Activities $18.17M $17.87M $38.41M
YoY Change -52.71% 49.79% 134.64%
INVESTING ACTIVITIES
Capital Expenditures -$3.019M -$2.070M -$700.0K
YoY Change 331.29% -43.44% -60.89%
Acquisitions
YoY Change
Other Investing Activities $10.02M -$38.94M $30.12M
YoY Change -66.74% 464.35% 115.91%
Cash From Investing Activities $7.000M -$41.02M $29.42M
YoY Change -76.21% 288.08% 141.94%
FINANCING ACTIVITIES
Cash Dividend Paid $30.70M
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -24.29M 30.00K 0.000
YoY Change -97.46%
NET CHANGE
Cash From Operating Activities 18.17M 17.87M 38.41M
Cash From Investing Activities 7.000M -41.02M 29.42M
Cash From Financing Activities -24.29M 30.00K 0.000
Net Change In Cash 879.0K -23.12M 67.83M
YoY Change -98.7% -1010.24% 137.75%
FREE CASH FLOW
Cash From Operating Activities $18.17M $17.87M $38.41M
Capital Expenditures -$3.019M -$2.070M -$700.0K
Free Cash Flow $21.18M $19.94M $39.11M
YoY Change -45.83% 27.9% 115.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Net Income Loss
NetIncomeLoss
31357000 USD
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001524025
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-29
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-07-31
dei Document Transition Report
DocumentTransitionReport
false
us-gaap Net Income Loss
NetIncomeLoss
-12129000 USD
dei Entity File Number
EntityFileNumber
001-35535
dei Entity Registrant Name
EntityRegistrantName
TILLY’S, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-2164791
dei Entity Address Address Line1
EntityAddressAddressLine1
10 Whatney
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92618
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
609-5599
dei Security12b Title
Security12bTitle
Class A Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
TLYS
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81894000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76184000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
132955000 USD
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
66644000 USD
CY2021Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
64955000 USD
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
15939000 USD
CY2021Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
13143000 USD
CY2021Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
8724000 USD
CY2020Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
13287000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
86853000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
55698000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
68067000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7810000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6595000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3956000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
256344000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
212156000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
234204000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
216046000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
229864000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
245004000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
51172000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
52639000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
56805000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11601000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12797000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8458000 USD
CY2021Q3 us-gaap Assets
Assets
535163000 USD
CY2021Q1 us-gaap Assets
Assets
507456000 USD
CY2020Q3 us-gaap Assets
Assets
544471000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
59053000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
24983000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
48710000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23898000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30682000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19416000 USD
CY2021Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2021Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2020Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
23675000 USD
CY2021Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
13040000 USD
CY2021Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
13492000 USD
CY2020Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
9443000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16567000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9899000 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6891000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-11000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
53022000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
54503000 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
64470000 USD
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
948000 USD
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
632000 USD
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
339000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
166528000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
134191000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
172944000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
196018000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
211292000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1351000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
944000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
363931000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
222015000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1385000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Liabilities
Liabilities
346834000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
395903000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
165407000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
155437000 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
154386000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5782000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5135000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5849000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
12000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
20000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
171232000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
160622000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
148568000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
535163000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
507456000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
544471000 USD
CY2021Q3 us-gaap Revenues
Revenues
201952000 USD
CY2020Q3 us-gaap Revenues
Revenues
135845000 USD
us-gaap Revenues
Revenues
365109000 USD
us-gaap Revenues
Revenues
213134000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
127225000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-200000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
94171000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
235543000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
169866000 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
74727000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
41674000 USD
us-gaap Gross Profit
GrossProfit
129566000 USD
us-gaap Gross Profit
GrossProfit
43268000 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
48300000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
33965000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
88265000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
63960000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
26427000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
7709000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
41301000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-20692000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-102000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
311000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-218000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
720000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
26325000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
8020000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
41083000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-19972000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5927000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2754000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9726000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7843000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
20398000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
5266000 USD
us-gaap Net Income Loss
NetIncomeLoss
31357000 USD
us-gaap Net Income Loss
NetIncomeLoss
-12129000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30500000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29694000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30189000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29686000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31113000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29700000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30837000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29686000 shares
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
20398000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
5266000 USD
us-gaap Net Income Loss
NetIncomeLoss
31357000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-8000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-213000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-200000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-213000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20387000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5066000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
31349000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12342000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
174601000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
20398000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
148568000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
160622000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
20398000 USD
CY2021Q3 us-gaap Payments Of Dividends
PaymentsOfDividends
30710000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
531000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6423000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-11000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
171232000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
142994000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
5266000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
508000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-200000 USD
us-gaap Net Income Loss
NetIncomeLoss
-12129000 USD
us-gaap Net Income Loss
NetIncomeLoss
31357000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
30710000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
896000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9075000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-8000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
171232000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
159901000 USD
us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
51000 shares
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1009000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-213000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-213000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
148568000 USD
us-gaap Net Income Loss
NetIncomeLoss
31357000 USD
us-gaap Net Income Loss
NetIncomeLoss
-12129000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8809000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
9987000 USD
CY2021Q3 us-gaap Proceeds From Insurance Settlement Operating Activities
ProceedsFromInsuranceSettlementOperatingActivities
117000 USD
us-gaap Proceeds From Insurance Settlement Operating Activities
ProceedsFromInsuranceSettlementOperatingActivities
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
896000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1009000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
136000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
903000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-62000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
64000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
74000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
677000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1462000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
490000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8511000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
2997000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-5802000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
31272000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-11166000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1483000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2107000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
34077000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
28376000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5859000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
701000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-452000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2318000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
6668000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-299000 USD
tlys Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-3481000 USD
tlys Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
8802000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-524000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-225000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
37442000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
18843000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4250000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
10000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
29000 USD
us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
66625000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
15968000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
65000000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
70195000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10097000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
49977000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
23675000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
29677000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9075000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21635000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6002000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5710000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
62818000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
76184000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70137000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
81894000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
132955000 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
128000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
17790000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
828000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1571000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1845000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9790 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
7168 USD
CY2021Q3 us-gaap Number Of Stores
NumberOfStores
244 store
CY2021Q3 tlys Number Of States
NumberOfStates
33 State
CY2021Q3 us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Periods</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year ends on the Saturday closest to January 31. References to fiscal 2021 refer to the fiscal year ending January 29,<br/>2022. References to the fiscal quarters or first halves July 31, 2021 and August 1, 2020 refer to the thirteen and twenty-six week periods ended as of those dates, respectively.</span></div>
CY2020Q3 us-gaap Revenues
Revenues
135845000 USD
CY2021Q3 us-gaap Revenues
Revenues
201952000 USD
us-gaap Revenues
Revenues
365109000 USD
us-gaap Revenues
Revenues
213134000 USD
CY2021Q3 tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
CY2020Q3 tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
CY2021Q3 tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
CY2021Q3 tlys Number Of Stores Covid Lease Not Yet Negotiated
NumberOfStoresCOVIDLeaseNotYetNegotiated
10
CY2020Q3 tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
CY2021Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
3900000 USD
CY2021Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1400000 USD
CY2020Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
2100000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3400000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3100000 USD
tlys Unredeemed Awardsand Accumulated Points Expiration Period
UnredeemedAwardsandAccumulatedPointsExpirationPeriod
P365D
CY2021Q3 us-gaap Deferred Revenue
DeferredRevenue
5100000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
54072000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
64678000 USD
CY2021Q3 tlys Operating Lease Withheld Lease Payments
OperatingLeaseWithheldLeasePayments
400000 USD
CY2021Q1 us-gaap Deferred Revenue
DeferredRevenue
3900000 USD
CY2020Q3 us-gaap Deferred Revenue
DeferredRevenue
1800000 USD
CY2021Q3 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
2700000 USD
CY2020Q3 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
1500000 USD
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
4800000 USD
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
2400000 USD
CY2021Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P10Y
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
34493000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
43458000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
34470000 USD
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
15288000 USD
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
4846000 USD
CY2020Q3 us-gaap Variable Lease Cost
VariableLeaseCost
4453000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
65697000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
296868000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
47828000 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
249040000 USD
CY2021Q3 tlys Lessee Operating Lease Lease Not Yet Commenced Value
LesseeOperatingLeaseLeaseNotYetCommencedValue
2900000 USD
CY2021Q3 tlys Lessee Operating Lease Subsequent Modification
LesseeOperatingLeaseSubsequentModification
3600000 USD
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
15257000 USD
CY2021Q3 us-gaap Lease Cost
LeaseCost
20103000 USD
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y6M
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y10M24D
CY2020Q3 us-gaap Lease Cost
LeaseCost
19741000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
30882000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
31203000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
8736000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
8294000 USD
us-gaap Lease Cost
LeaseCost
39618000 USD
us-gaap Lease Cost
LeaseCost
39497000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
34452000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
20446000 USD
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0640
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0426
CY2021Q1 tlys Marketable Securities Accumulated Gross Unrealized Loss
MarketableSecuritiesAccumulatedGrossUnrealizedLoss
1000 USD
CY2021Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
64955000 USD
tlys Income Tax Expense Benefit Narrative
IncomeTaxExpenseBenefitNarrative
9700000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.237
tlys Income Tax Expense Benefit Narrative
IncomeTaxExpenseBenefitNarrative
-7800000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.393
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
1000000 USD
CY2021Q3 us-gaap Marketable Securities
MarketableSecurities
66628000 USD
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
66644000 USD
CY2021Q1 us-gaap Marketable Securities
MarketableSecurities
64928000 USD
CY2021Q1 tlys Marketable Securities Accumulated Gross Unrealized Gain
MarketableSecuritiesAccumulatedGrossUnrealizedGain
28000 USD
CY2021Q3 tlys Marketable Securities Accumulated Gross Unrealized Gain
MarketableSecuritiesAccumulatedGrossUnrealizedGain
16000 USD
CY2021Q3 tlys Marketable Securities Accumulated Gross Unrealized Loss
MarketableSecuritiesAccumulatedGrossUnrealizedLoss
0 USD
CY2020Q3 tlys Impaired Long Lived Assets Heldand Used Carrying Amount
ImpairedLongLivedAssetsHeldandUsedCarryingAmount
570000 USD
tlys Impaired Long Lived Assets Heldand Used Carrying Amount
ImpairedLongLivedAssetsHeldandUsedCarryingAmount
176000 USD
tlys Impaired Long Lived Assets Heldand Used Fair Value
ImpairedLongLivedAssetsHeldandUsedFairValue
0 USD
CY2020Q3 us-gaap Marketable Securities
MarketableSecurities
15938000 USD
CY2020Q3 tlys Marketable Securities Accumulated Gross Unrealized Gain
MarketableSecuritiesAccumulatedGrossUnrealizedGain
1000 USD
tlys Impaired Long Lived Assets Heldand Used Carrying Amount
ImpairedLongLivedAssetsHeldandUsedCarryingAmount
903000 USD
tlys Impaired Long Lived Assets Heldand Used Fair Value
ImpairedLongLivedAssetsHeldandUsedFairValue
40000 USD
CY2020Q3 tlys Impaired Long Lived Assets Heldand Used Fair Value
ImpairedLongLivedAssetsHeldandUsedFairValue
0 USD
CY2020Q3 tlys Marketable Securities Accumulated Gross Unrealized Loss
MarketableSecuritiesAccumulatedGrossUnrealizedLoss
0 USD
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
15939000 USD
CY2021Q3 tlys Numberof Stores Testedfor Impairment
NumberofStoresTestedforImpairment
3 store
tlys Impaired Long Lived Assets Heldand Used Fair Value
ImpairedLongLivedAssetsHeldandUsedFairValue
40000 USD
tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
1 store
CY2021Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
30.7 USD
CY2021Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
63000000 USD
CY2020Q3 us-gaap Line Of Credit
LineOfCredit
23700000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
100000 USD
tlys Impaired Long Lived Assets Heldand Used Carrying Amount
ImpairedLongLivedAssetsHeldandUsedCarryingAmount
176000 USD
CY2020Q3 tlys Numberof Stores Testedfor Impairment
NumberofStoresTestedforImpairment
37 store
tlys Numberof Stores Testedfor Impairment
NumberofStoresTestedforImpairment
11 store
tlys Numberof Stores Testedfor Impairment
NumberofStoresTestedforImpairment
40 store
CY2021Q3 tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
1 store
CY2020Q3 tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
7 store
tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
1 store
tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
10 store
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2602212 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.19
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
508700 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.79
CY2021Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1154258 shares
CY2021Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.86
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
258886 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
9.31
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
32000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
16.26
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1665768 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.88
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M24D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10014000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
485355 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.47
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y1M6D
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2208000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.56
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.62
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.67
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.11
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y7M6D
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y4M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y3M18D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.594
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.597
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.599
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.573
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.005
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.004
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
531000 USD
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
508000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
896000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1009000 USD
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4900000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M24D
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
20398000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
5266000 USD
us-gaap Net Income Loss
NetIncomeLoss
31357000 USD
us-gaap Net Income Loss
NetIncomeLoss
-12129000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30500000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29694000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30189000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29686000 shares
CY2021Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
613000 shares
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
648000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31113000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29700000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30837000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29686000 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
679000 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2644000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
823000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2665000 shares

Files In Submission

Name View Source Status
0001628280-21-018255-index-headers.html Edgar Link pending
0001628280-21-018255-index.html Edgar Link pending
0001628280-21-018255.txt Edgar Link pending
0001628280-21-018255-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
q22021ex311.htm Edgar Link pending
q22021ex312.htm Edgar Link pending
q22021ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tlys-20210731.htm Edgar Link pending
tlys-20210731.xsd Edgar Link pending
tlys-20210731_cal.xml Edgar Link unprocessable
tlys-20210731_def.xml Edgar Link unprocessable
tlys-20210731_htm.xml Edgar Link completed
tlys-20210731_lab.xml Edgar Link unprocessable
tlys-20210731_pre.xml Edgar Link unprocessable